For decades, metformin has been considered the gold standard treatment for type 2 diabetes.

It has helped millions of people control their blood sugar, yet one important question has remained unanswered: How does metformin actually work?

For years, researchers believed the answer was simple. Metformin mainly reduced glucose production in the liver while also improving metabolic function in the intestines.

However, a new study from Baylor College of Medicine, published in Science Advances, suggests that the drug has been working in another unexpected location all along—the brain.

This discovery could reshape how scientists understand metformin and may lead to new approaches for diabetes treatment in the future.

Scientists Found a Previously Unknown Brain Pathway

The research team focused on a region deep inside the brain called the ventromedial hypothalamus (VMH), an area known for regulating energy balance and glucose metabolism.

Within this region, they investigated a protein called Rap1. Their experiments revealed that metformin lowers blood sugar by suppressing Rap1 activity inside the VMH.

Until now, this mechanism had gone unnoticed despite metformin being prescribed worldwide for more than 60 years.

What Happens When Rap1 Is Missing?

To better understand Rap1's role, researchers created genetically modified mice that lacked Rap1 specifically within the VMH.

These mice were fed a high-fat diet to mimic type 2 diabetes and then treated with low-dose metformin.

The results were striking.

Unlike normal diabetic mice, those without Rap1 showed almost no improvement in blood glucose levels after taking metformin.

Interestingly, other diabetes medications—including insulin and GLP-1 receptor agonists—continued to lower blood sugar normally.

This suggests that Rap1 appears to be uniquely involved in metformin's mechanism rather than general glucose regulation.

Tiny Amounts of Metformin in the Brain Produced Significant Effects

Researchers also wanted to determine whether metformin could act directly within the brain.

Instead of giving the drug orally, they injected extremely small amounts directly into the brains of diabetic mice.

Even though these doses were thousands of times lower than standard oral doses, blood glucose levels still dropped significantly.

This finding suggests that the brain is remarkably sensitive to metformin and may respond at concentrations far lower than those required in other organs.

Specific Brain Cells Become Active

The team identified a group of neurons known as SF1 neurons, which are located in the VMH.

When metformin reached the brain, these neurons became more active.

However, this effect disappeared completely in mice lacking Rap1.

Electrical recordings confirmed that Rap1 is required for metformin to activate these neurons,

indicating that this protein serves as an essential switch connecting metformin to the brain's glucose-control network.

Metformin May Work Through Multiple Organs

For many years, metformin's primary targets were thought to be the liver and digestive tract.

This new research suggests a more complete picture.

Rather than acting in just one organ, metformin may lower blood sugar through several pathways simultaneously:

• Liver: reduces glucose production.
• Intestines: influences glucose metabolism and nutrient handling.
• Brain: suppresses Rap1 activity, activates SF1 neurons, and helps regulate blood glucose.

Researchers also noted that while the liver and intestines require relatively high drug concentrations, the brain appears to respond to much lower levels.

What Could This Mean for Future Diabetes Treatments?

Although only a handful of diabetes medications are currently known to act on the brain, this study suggests metformin has likely been doing so for decades without researchers realizing it.

Understanding this newly discovered pathway could eventually help scientists:

• Develop diabetes medications that directly target the brain.
• Improve glucose control with lower drug doses.
• Design treatments with fewer side effects.
• Better understand why metformin provides benefits beyond blood sugar management.

Could This Also Explain Metformin's Other Benefits?

Metformin has attracted attention for potential health effects beyond diabetes, including research suggesting possible roles in healthy aging, brain function, and metabolic health.

The Baylor researchers plan to investigate whether the same Rap1 signaling pathway discovered in this study also contributes to these additional benefits.

If confirmed, the findings could expand our understanding of why metformin continues to be one of the world's most widely studied medications.

Key Takeaways

Metformin has been used safely for over six decades, but scientists are still uncovering how it works.

The latest research suggests that the drug doesn't simply act in the liver and gut—it also directly influences the brain by suppressing Rap1 activity inside the ventromedial hypothalamus. This activates neurons involved in glucose regulation and helps lower blood sugar, even at extremely small concentrations.

While more human research is needed, these findings provide a new perspective on one of the most commonly prescribed diabetes medications and may open the door to more targeted treatments in the years ahead.

Disclaimer: This article summarizes recent scientific research for educational purposes only. The findings are based primarily on preclinical studies and should not be interpreted as medical advice. Always consult your healthcare provider before making changes to your diabetes treatment.